(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.36%) $28.77
(2.90%) $1 015.00
(0.35%) $0.936
(0.64%) $10.67
(0.51%) $0.792
(0.87%) $88.25
4.01% $ 3.89
Live Chart Being Loaded With Signals
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing...
Stats | |
---|---|
Volumen de hoy | 27 020 |
Volumen promedio | 148 795 |
Capitalización de mercado | 196.13M |
EPS | $-0.290 ( Q1 | 2024-05-06 ) |
Próxima fecha de ganancias | ( $-0.290 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.02 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0510 (1.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-29 | Imran Mir A | Buy | 50 000 | Stock Option (Right to Buy) |
2024-05-29 | Farquharson Andrew | Buy | 50 000 | Stock Option (Right to Buy) |
2024-05-29 | Nanavaty Maulik | Buy | 50 000 | Stock Option (Right to Buy) |
2024-05-29 | Debuono Laureen | Buy | 50 000 | Stock Option (Right to Buy) |
2024-05-29 | Ausiello Dennis A | Buy | 50 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
19.97 |
Last 99 transactions |
Buy: 11 996 470 | Sell: 8 157 844 |
Volumen Correlación
Rani Therapeutics Correlación
10 Correlaciones Más Positivas | |
---|---|
ABIO | 0.931 |
GRIN | 0.922 |
SGRP | 0.921 |
GALT | 0.915 |
CSTE | 0.912 |
AMRK | 0.906 |
GAIA | 0.89 |
LE | 0.888 |
NSYS | 0.885 |
MDIA | 0.884 |
10 Correlaciones Más Negativas | |
---|---|
ZD | -0.91 |
MBIO | -0.902 |
INVE | -0.893 |
HELE | -0.893 |
POAI | -0.893 |
RGP | -0.892 |
HOFT | -0.89 |
EFTR | -0.887 |
BSMU | -0.883 |
LSXMK | -0.881 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rani Therapeutics Correlación - Moneda/Commodity
Rani Therapeutics Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-822 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-822 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.31M (0.00 %) |
EPS: | $-2.66 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.445 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Rani Therapeutics
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico